Medical Director, Provision Radiation Therapy
Radiation Oncology
Dr. Allen G. Meek, MD
|
|
Give Review
Allen Meek is an expert in the field of Radiation Oncology. He graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received 21 awards: "Continuously listed in Castle-Connolly guide to top Doctors NY metro area", "Newsdays Top Oncologist on Long Island", "CMS Meaningful Use Stage 1 Certification", "Top Doctors: New York Metro Area", "Newsday - Top Doctors on Long Island", "Superb AVVO rating", "Sons of Italy Cancer Research Award", "New York State Assembly Citation for 25 years of Outstanding Service", "Elected to Fellowship American College of Radiology", "Selected for Americas Best Doctors", "Selected for Americas Top Physicians", "Humanitarian Award", "Medical Man of the Year", "Medical Person of the Year", "United University Professors Excellence Award for Professional Service", "Clinical Fellowships", "Letter of Commendation", "Phi Beta Kappa", "Sigma Xi", "George Plimpton Fellowship" and "Doughty Prize (best honors thesis in Chemistry)". Dr. Allen G. Meek is a published MD. He has 33 publications published. The most current publication "Breast radiotherapy and lymphedema." Allen G. Meek accepts Medicare payments and is listed with Medicare.gov.
Publications
- Evaluation of the eclipse electron Monte Carlo dose calculation for small fields.
- Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy.
- Impaired permeability in radiation-induced lung injury detected by technetium-99m-DTPA lung clearance.
- A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostate.
- Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy: a preliminary study.
- Unified dosimetry index (UDI): a figure of merit for ranking treatment plans.
- Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.
- Assessment of geometric treatment accuracy using time-lapse display of electronic portal images.
- An assessment of a film enhancement system for use in a radiation therapy department.
- Primary, adjuvant, and palliative radiation therapy.
- Tests of an electron monitor for routine quality control measurements of electron energies.
- A new isocenter shift method for ideal geometric matching of two adjacent fields.
- Breast radiotherapy and lymphedema.
- Cytologic and histologic changes in irradiated loops of transplanted small bowel.
- Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors.
- Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors.
- Energy response of agar-alanine free radical dosimetry to therapeutic electron beams.
- A rapid colour stabilization technique for radiochromic film dosimetry.
- Fractionation considerations for boron neutron capture therapy: the perspective of a clinician.
- Depth dose and profile analysis using Library Least-Squares method.
- Effect of delayed radiation therapy on local control in breast conservation therapy.
- Investigation of a phase-only correlation technique for anatomical alignment of portal images in radiation therapy.
- Androgen induction of urokinase gene expression in LNCaP cells is dependent on their interaction with the extracellular matrix.
- The role of passenger cells in the induction of allogeneic unresponsiveness to canine renal allografts.
- Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients.
- Immunosuppressive strategies for the induction of unresponsiveness to canine renal allografts.
- Synergistic effects of cyclosporine and steroid therapy in the induction of specific unresponsiveness to DLA-identical canine renal allografts.
- The preparation of an autologous saliva for use with patients undergoing therapeutic radiation for head and neck cancer.
- Clinical use of a wing field with transmission block for the treatment of the pelvis including the inguinal node.
- Analysis of 5-iodo-2''-deoxyuridine incorporation in murine melanoma for photon activation therapy.
- Concurrent radiochemotherapy in advanced breast cancer.
- Synergistic effects of combined immunosuppressive modulation. I. Unresponsiveness to dendritic cell-depleted renal allografts in dogs exposed to total-lymphoid irradia...
Schools
Johns Hopkins Univ Sch Of Med
Johns Hopkins Hospital
Doctors Specialties
- Internal Medicine
- Radiation Oncology
- Radiology
Accepted Insurances
Awards
- Continuously listed in Castle-Connolly guide to top Doctors NY metro area
- Newsday’s “Top Oncologist on Long Islandâ€Â
- CMS Meaningful Use Stage 1 Certification
- Top Doctors: New York Metro Area
- Newsday - Top Doctors on Long Island
- Superb AVVO rating
- Sons of Italy “Cancer Research Awardâ€Â
- New York State Assembly Citation for 25 years of Outstanding Service
- Elected to Fellowship American College of Radiology
- Selected for America’s Best Doctors
- Selected for America’s Top Physicians
- Humanitarian Award
- Medical Man of the Year
- Medical Person of the Year
- United University Professors Excellence Award for Professional Service
- Clinical Fellowships
- Letter of Commendation
- Phi Beta Kappa
- Sigma Xi
- George Plimpton Fellowship
- Doughty Prize (best honors thesis in Chemistry)
Education
-
Johns Hopkins University School of Medicine
Hospital
-
Stony Brook University Medical Center
Drug Facts
| NPI NUMBER | 1699718015 | |
| NPPES Provider LastName | MEEK | |
| NPPES Provider FirstName | ALLEN | |
| NPPES Provider ZIPCode | 379091327 | |
| NPPES Provider State | TN | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 47.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 29.79 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699718015 |
| Last Name Of The Provider | MEEK |
| First Name Of The Provider | ALLEN |
| View All |
Similar Doctors
|
|
Dr. Ann C. Cea, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander M. Stessin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bong S. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wyman A. Bethune, MD |
|
|
Dr. Tae L. Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward S. Valentine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamara Weiss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Priya P. Patel, MB BS |
|
|
Dr. Juan Lin, MD |
|
|
Dr. Nirvani T. Goolsarran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter B. Dashkoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olena Ksovreli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lamah Massasati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neelima Kanagala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashwinii K. Hari, MD
This Doctor is OpenDoctor Recommended.
|